{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T08:36:47Z","timestamp":1774168607319,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1208\/s12248-017-0157-6","type":"journal-article","created":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T15:16:38Z","timestamp":1512659798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Pharmacoimaging of Blood-Brain Barrier Permeable (FDG) and Impermeable (FLT) Substrates After Intranasal (IN) Administration"],"prefix":"10.1208","volume":"20","author":[{"given":"Laura L. Boles","family":"Ponto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Mundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Thede-Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Leonard Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Sunderland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Acevedo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,7]]},"reference":[{"issue":"11","key":"157_CR1","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge WM. Drug transport across the blood-brain barrier. J Cereb Blood Flow Metab. 2012;32(11):1959\u201372. \nhttps:\/\/doi.org\/10.1038\/jcbfm.2012.126\n\n.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"7","key":"157_CR2","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","volume":"64","author":"JJ Lochhead","year":"2012","unstructured":"Lochhead JJ, Thorne RG. Intranasal delivery of biologics to the central nervous system. Adv Drug Deliv Rev. 2012;64(7):614\u201328. \nhttps:\/\/doi.org\/10.1016\/j.addr.2011.11.002\n\n.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"157_CR3","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"S Dhuria","year":"2010","unstructured":"Dhuria S, Hanson L, Frey W. Intranasal delivery to the central nervous system: mechanism and experimental considerations. J Pharm Sci. 2010;99(4):1654\u201373. \nhttps:\/\/doi.org\/10.1002\/jps.21924\n\n.","journal-title":"J Pharm Sci"},{"issue":"1\u20132","key":"157_CR4","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1006\/mgme.2001.3236","volume":"74","author":"DHS Silverman","year":"2001","unstructured":"Silverman DHS, Phelps ME. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke. Mol Genet Metab. 2001;74(1\u20132):128\u201338. \nhttps:\/\/doi.org\/10.1006\/mgme.2001.3236\n\n.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"157_CR5","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2967\/jnumed.111.096578","volume":"53","author":"NI Bohnen","year":"2012","unstructured":"Bohnen NI, Djang DSW, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med. 2012;53(1):59\u201371. \nhttps:\/\/doi.org\/10.2967\/jnumed.111.096578\n\n.","journal-title":"J Nucl Med"},{"issue":"12","key":"157_CR6","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/MNM.0b013e32832ee93b","volume":"30","author":"T Barwick","year":"2009","unstructured":"Barwick T, Bencherif B, Mountz JM, Avril N, Molecular PET. PET\/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation. [review]. Nucl Med Commun. 2009;30(12):908\u201317. \nhttps:\/\/doi.org\/10.1097\/MNM.0b013e32832ee93b\n\n.","journal-title":"Nucl Med Commun"},{"issue":"4","key":"157_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.nucmedbio.2010.02.005","volume":"37","author":"Y Menda","year":"2010","unstructured":"Menda Y, Boles Ponto LL, Dornfeld KJ, Tewson TJ, Watkins GL, Gupta AK, et al. Investigation of the pharmacokinetics of 3\u2032-deoxy-3\u2032-[18F]fluorothymidine uptake in the bone marrow before and early after initiation of chemoradiation therapy in head and neck cancer. Nucl Med Biol. 2010;37(4):433\u20138. \nhttps:\/\/doi.org\/10.1016\/j.nucmedbio.2010.02.005\n\n.","journal-title":"Nucl Med Biol"},{"issue":"10","key":"157_CR8","first-page":"1592","volume":"47","author":"A Agool","year":"2006","unstructured":"Agool A, Schot BW, Jager PL, Vellenga E. 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment. J Nucl Med. 2006;47(10):1592\u20138.","journal-title":"J Nucl Med"},{"issue":"3","key":"157_CR9","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.ijrobp.2010.12.009","volume":"81","author":"SM McGuire","year":"2011","unstructured":"McGuire SM, Menda Y, Boles Ponto LL, Gross B, Buatti J, Bayouth JE. 3\u2032-deoxy-3\u2032-[18F]fluorothymidine PET quantification of bone marrow response to radiation dose. International Journal of Radiation Oncology*Biology*Physics. 2011;81(3):888\u201393. \nhttps:\/\/doi.org\/10.1016\/j.ijrobp.2010.12.009\n\n.","journal-title":"International Journal of Radiation Oncology*Biology*Physics."},{"issue":"1","key":"157_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.ijrobp.2016.04.009","volume":"96","author":"SM McGuire","year":"2016","unstructured":"McGuire SM, Bhatia SK, Sun W, Jacobson GM, Menda Y, Ponto LL, et al. Using [18F]Fluorothymidine imaged with positron emission tomography to quantify and reduce hematologic toxicity due to chemoradiation therapy for pelvic cancer patients. International Journal of Radiation Oncology*Biology*Physics. 2016;96(1):228\u201339. \nhttps:\/\/doi.org\/10.1016\/j.ijrobp.2016.04.009\n\n.","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"issue":"12","key":"157_CR11","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1097\/01.rlu.0000246820.14892.d2","volume":"31","author":"TMD Saga","year":"2006","unstructured":"Saga TMD, Kawashima H, Araki N, Takahashi JA, Nakashima Y, Higashi T, et al. Evaluation of primary brain tumors with FLT-PET: usefulness and limitations. Clin Nucl Med. 2006;31(12):774\u201380. \nhttps:\/\/doi.org\/10.1097\/01.rlu.0000246820.14892.d2\n\n.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"157_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s00259-012-2275-9","volume":"40","author":"A Shinomiya","year":"2013","unstructured":"Shinomiya A, Kawai N, Okada M, Miyake K, Nakamura T, Kushida Y, et al. Evaluation of 3\u2032-deoxy-3\u2032-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas. Eur J Nucl Med Mol Imaging. 2013;40(2):175\u201385. \nhttps:\/\/doi.org\/10.1007\/s00259-012-2275-9\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"157_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ejpb.2015.11.014","volume":"99","author":"T Shingaki","year":"2016","unstructured":"Shingaki T, Katayama Y, Nakaoka T, Irie S, Onoe K, Okauchi T, et al. Visualization of drug translocation in the nasal cavity and pharmacokinetic analysis on nasal drug absorption using positron emission tomography in the rat. Eur J Pharm Biopharm. 2016;99:45\u201353. \nhttps:\/\/doi.org\/10.1016\/j.ejpb.2015.11.014\n\n.","journal-title":"Eur J Pharm Biopharm"},{"issue":"1","key":"157_CR14","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0378-5173(94)00274-9","volume":"116","author":"M Donovan","year":"1995","unstructured":"Donovan M, Zhou M. Drug effects on in vivo nasal clearance in rats. Int J Pharm. 1995;116(1):77\u201386. \nhttps:\/\/doi.org\/10.1016\/0378-5173(94)00274-9\n\n.","journal-title":"Int J Pharm"},{"issue":"1-2","key":"157_CR15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0169-409X(97)00059-8","volume":"29","author":"E Martin","year":"1998","unstructured":"Martin E, Schipper N, Verhoef J, Markus F. Nasal mucociliary clearance as a factor in nasal drug delivery. Adv Drug Deliv Rev. 1998;29(1-2):13\u201338. \nhttps:\/\/doi.org\/10.1016\/S0169-409X(97)00059-8\n\n.","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"157_CR16","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11051-008-9452-6","volume":"11","author":"B Wang","year":"2009","unstructured":"Wang B, Feng W, Zhu M, Wang Y, Wang M, Gu Y, et al. Neurotoxicity of low-dose repeatedly intranasal instillation of nano-and submicron-sized ferric oxide particles in mice. J Nanopart Res. 2009;11(1):41\u201353. \nhttps:\/\/doi.org\/10.1007\/s11051-008-9452-6\n\n.","journal-title":"J Nanopart Res"},{"issue":"4","key":"157_CR17","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.neuro.2011.12.001","volume":"33","author":"R Lucchini","year":"2012","unstructured":"Lucchini R, Dorman D, Elder A, Veronesi B. Neurological impacts from inhalation of pollutants and the nose-brain connection. Neurotoxicology. 2012;33(4):838\u201341. \nhttps:\/\/doi.org\/10.1016\/j.neuro.2011.12.001\n\n.","journal-title":"Neurotoxicology"},{"issue":"8","key":"157_CR18","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1289\/ehp.9030","volume":"114","author":"A Elder","year":"2006","unstructured":"Elder A, Gelein R, Silva V, Feikert T, Opanashuk L, Carter J, et al. Translocation of inhaled ultrafine manganese oxide particles to the central nervous system. Environ Health Perspect. 2006;114(8):1172\u20138. \nhttps:\/\/doi.org\/10.1289\/ehp.9030\n\n.","journal-title":"Environ Health Perspect"},{"issue":"1","key":"157_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1006\/viro.1993.1248","volume":"194","author":"E Barnett","year":"1993","unstructured":"Barnett E, Perlman S. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse herpes simplex virus. Virology. 1993;194(1):185\u201391. \nhttps:\/\/doi.org\/10.1006\/viro.1993.1248\n\n.","journal-title":"Virology"},{"issue":"1","key":"157_CR20","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.1038\/s41598-017-03894-4","volume":"7","author":"H Shiga","year":"2017","unstructured":"Shiga H, Taki J, Okuda K, Watanabe N, Tonami H, Nakagawa H, et al. Prognostic value of olfactory nerve damage measured with thallium-based olfactory imaging in patients with idiopathic olfactory dysfunction. Sci Rep. 2017;7(1):3581. \nhttps:\/\/doi.org\/10.1038\/s41598-017-03894-4\n\n.","journal-title":"Sci Rep"},{"issue":"2","key":"157_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057671","volume":"8","author":"H Shiga","year":"2013","unstructured":"Shiga H, Taki J, Washiyama K, Yamamoto J, Kinase S, Okuda K, et al. Assessment of olfactory nerve by SPECT-MRI image with nasal Thallium-201 administration in patients with olfactory impairments in comparison to healthy volunteers. PLoS One. 2013;8(2):e57671. \nhttps:\/\/doi.org\/10.1371\/journal.pone.0057671\n\n.","journal-title":"PLoS One"},{"issue":"6","key":"157_CR22","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1007\/s11307-010-0461-3","volume":"13","author":"H Shiga","year":"2011","unstructured":"Shiga H, Taki J, Yamada M, Washiyama K, Amano R, Matsuura Y, et al. Evaluation of the olfactory nerve transport function by SPECT-MRI fusion image with nasal Thallium-201 administration. Mol Imaging Biol. 2011;13(6):1262\u20136. \nhttps:\/\/doi.org\/10.1007\/s11307-010-0461-3\n\n.","journal-title":"Mol Imaging Biol"},{"issue":"2","key":"157_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2967\/jnumed.110.081539","volume":"52","author":"S Yamashita","year":"2011","unstructured":"Yamashita S, Takashima T, Kataoka M. Oh H, Sakuma S, Takahashi M, et al. PET imaging of the gastrointestinal absorption of orally administered drugs in conscious and anesthetized rats. J Nucl Med. 2011;52(2):249\u201356. \nhttps:\/\/doi.org\/10.2967\/jnumed.110.081539\n\n.","journal-title":"J Nucl Med"},{"issue":"6","key":"157_CR24","doi-asserted-by":"crossref","first-page":"C1277","DOI":"10.1152\/ajpcell.00296.2010","volume":"299","author":"Y AS","year":"2010","unstructured":"AS Y, Hirayama BA, Timbol G, Liu J, Basarah E, Kepe V, et al. Functional expression of SGLTs in rat brain. Am J Physiol Cell Physiol. 2010;299(6):C1277\u2013C84.","journal-title":"Am J Physiol Cell Physiol"},{"issue":"2","key":"157_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.2967\/jnmt.106.036129","volume":"35","author":"N Nair","year":"2007","unstructured":"Nair N, Agrawal A, Jaiswar R. Substitution of oral 18F-FDG for intravenous 18F-FDG in PET scanning. Journal of Nuclear Medicine Technology. 2007;35(2):100\u20134. \nhttps:\/\/doi.org\/10.2967\/jnmt.106.036129\n\n.","journal-title":"Journal of Nuclear Medicine Technology"},{"issue":"8","key":"157_CR26","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.nucmedbio.2012.07.007","volume":"39","author":"DA Plotnik","year":"2012","unstructured":"Plotnik DA, Asher C, Chu SK, Miyaoka RS, Garwin GG, Johnson BW, et al. Levels of human equilibrative nucleoside transporter-1 are higher in proliferating regions of A549 tumor cells grown as tumor xenografts in vivo. Nucl Med Biol. 2012;39(8):1161\u20136. \nhttps:\/\/doi.org\/10.1016\/j.nucmedbio.2012.07.007\n\n.","journal-title":"Nucl Med Biol"},{"issue":"9","key":"157_CR27","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.2967\/jnumed.110.076794","volume":"51","author":"DA Plotnik","year":"2010","unstructured":"Plotnik DA, Emerick LE, Krohn KA, Unadkat JD, Schwartz JL. Different modes of transport for 3H-thymidine, 3H-FLT, and 3H-FMAU in proliferating and nonproliferating human tumor cells. J Nucl Med. 2010;51(9):1464\u201371. \nhttps:\/\/doi.org\/10.2967\/jnumed.110.076794\n\n.","journal-title":"J Nucl Med"},{"issue":"7","key":"157_CR28","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.nucmedbio.2011.03.009","volume":"38","author":"DA Plotnik","year":"2011","unstructured":"Plotnik DA, McLaughlin LJ, Chan J, Redmayne-Titley JN, Schwartz JL. The role of nucleoside\/nucleotide transport and metabolism in the uptake and retention of 3\u2032-fluoro-3\u2032-deoxythymidine in human B-lymphoblast cells. Nucl Med Biol. 2011;38(7):979\u201386. \nhttps:\/\/doi.org\/10.1016\/j.nucmedbio.2011.03.009\n\n.","journal-title":"Nucl Med Biol"},{"issue":"1","key":"157_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2967\/jnumed.108.055152","volume":"50","author":"EP Visser","year":"2009","unstructured":"Visser EP, Disselhorst JA, Brom M, Laverman P, Gotthardt M, Oyen WJG, et al. Spatial resolution and sensitivity of the Inveon small-animal PET scanner. J Nucl Med. 2009;50(1):139\u201347. \nhttps:\/\/doi.org\/10.2967\/jnumed.108.055152\n\n.","journal-title":"J Nucl Med"},{"key":"157_CR30","unstructured":"Ponto LLB, Huang J, Walsh SA, Acevedo MR, Mundt C, Sunderland J, et al. Demonstration of nucleoside transporter activity in the nose-to-brain distribution of [18F]Fluorothymidine using PET imaging. AAPS J."}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12248-017-0157-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0157-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-017-0157-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T14:41:13Z","timestamp":1523889673000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12248-017-0157-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["157"],"URL":"https:\/\/doi.org\/10.1208\/s12248-017-0157-6","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,7]]},"article-number":"15"}}